Tagged: UCSF - UC Berkeley Joint Graduate Group in Bioengineering

UCSF lab sends filters to hurricane-ravaged Puerto Rico

Burchard Lab colleagues step up to help residents of the island get fresh water.

Hiding in plain sight

A tiny implant promises to simplify how glaucoma drugs are administered, making life easier for aging patients.

Novel diabetes treatment developed in Desai Lab to power SF-area startup

A UC San Francisco-created, insulin-generating implant that utilizes nanotechnology is closer to becoming a real treatment for diabetes, after being acquired by a San Francisco-based startup.

Wired magazine visits The Kidney Project

Kidney failure is a debilitating and ultimately deadly illness, and a health policy crisis. With 468,000 people on dialysis in the U.S., costing the government $31 billion dollars a year, very little money is spent on researching alternatives to current treatments.

Update from the Dean - September 2017

Strategic plan progress report. Research: Driving the development of innovative and precise drugs, medical devices, and diagnostic tests. Flu treatments; Tackling antimalarial resistance; Attacking hard targets; Plotting cell maps; Safer opioid pain killer; Cellular construction; New products through bioengineering; Regulatory science leadership; Tobacco burden in vulnerable populations; Economics of disease; Precision medicine. Education: Preparing leaders who think critically, work across fields, and lead in rapidly changing marketplaces. PharmD curriculum for 2018 and beyond; Transforming teaching; Coursework in regulatory science and translational medicine; Interdisciplinary exposure. Patient Care: Reframing how medication needs of patients are met. Importance of health information exchange; Outcomes research; Treating patients with more precise medications. People: Supporting our agents of change—our faculty, staff, and alumni. New faculty leaders; Housing and child care; Staff support and engagement; PharmD admissions; Unconscious bias. Framework for Success: Ensuring the School has the framework needed to excel. Support for enabling technology centers; Philanthropic support; Online presence.

Using antibiotics to stop contamination in cell cultures changes them, study finds

The common lab practice of adding antibiotics to cell cultures to prevent contamination can actually induce genetic changes in the cells, a paper senior-authored by Nadav Ahituv, PhD, found. Ahituv is a faculty member in the Department of Bioengineering and Therapeutic Sciences, a joint department of the UCSF Schools of Pharmacy and Medicine.

Meet D’Anne Duncan

The newest face on campus is D’Anne Duncan, PhD, who just moved here from Nashville, Tennessee.

Meet BTS Alum Adam Mendelsohn

Adam Mendelsohn, PhD, is co-founder and CEO of Nano Precision Medical, Inc., an Emeryville-based startup company that is developing a rice-grain-sized subdermal implant that delivers medicine at constant rates over time. His company is pursuing a type-2 diabetes application as their lead program; it is meant to replace the need for frequent injections with a very small, long-term implant.

Pages